** Shares in Ambu AMBUb.CO fall 1.4%, pares losses after
falling as much as 4.4%, after the Danish medical equipment
maker reported a Q1 slight net profit and FCF before
acquisitions miss
** Ambu's Q1 net profit is a 3.6% miss "on slightly higher
net financials and tax," says J.P. Morgan in a note
** The broker also notes the Q1 FCF before acquisitions
which was DKK 69 million ($9.63 million)compared to the
consensus of DKK 130 million
** The company previously raised its 2024/25 organic growth
outlook, saying it is "mainly driven by better-than-expected
revenue growth in Anaesthesia & Patient Monitoring, driven by
price increases and solid volume growth"
** JPM however says that pulmonology growth was better than
expected but "benefitted from an order timing tailwind in Q1"
** Up to the previous session's close, shares were up 34%
YTD
($1 = 7.1614 Danish crowns)
(Reporting by Vera Dvorakova)
((vera.dvorakova@thomsonreuters.com))